Immunowake logo

Immunowake Funding & Investors

Birmingham, AL

Immunowake is a biotechnology company that focuses on identifying new therapies for patients who do not respond to existing immunotherapies. Immunotherapy involves harnessing the body’s immune system to identify and kill cancer cells in the same way pathogens are identified and targeted. Recent breakthroughs in cancer immunotherapy have demonstrated that powerful anti-tumor responses can be achieved by activating antigen-specific T-cells.

immunowake.com

Total Amount Raised: $23,000,000

Immunowake Funding Rounds

  • Series A

    $20,000,000

    Series A Investors

    Hyfinity Investments
    South China Venture Capital
    HEDA Ventures
    Lapam Capital
  • Seed

    $3,000,000

Funding info provided by Diffbot.